QualifyHQ Logo

Amia

Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems expands the range of targetable genomic sites and increases the precision of genetic modifications, bringing gene editing to the next level of specificity and safety, which are required for therapeutic applications.

Founded

2018

Revenue

$500K - $1.0M

Funding

$6.3M

View similar companies

Qualify this Company in

minutes

While other tools waste time, we help you qualify better-fit companies in minutes, so your pipeline stays healthy, your team stays productive, and your deals move faster.

Start free trial

Start 7-Day Free Trial